Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Metabolic Control”

353 trials

Showing 20 of 353 results

Large-scale testing (Phase 3)Study completedNCT02284893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 461
Large-scale testing (Phase 3)Study completedNCT00509236
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Who this might be right for
Diabetes Mellitus, Type 2End-Stage Kidney Disease
Merck Sharp & Dohme LLC 129
Testing effectiveness (Phase 2)Study completedNCT02113332
What this trial is testing

Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections

Who this might be right for
Type 2 Diabetes Mellitus
Vastra Gotaland Region 124
Large-scale testing (Phase 3)Study completedNCT00087516
What this trial is testing

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 741
Large-scale testing (Phase 3)Study completedNCT00086515
What this trial is testing

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC 701
Large-scale testing (Phase 3)Study completedNCT00701090
What this trial is testing

Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

Who this might be right for
Type 2 Diabetes Mellitus, Non Insulin DependentDiabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 1,035
Large-scale testing (Phase 3)Study completedNCT02273050
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,136
Testing effectiveness (Phase 2)Study completedNCT01240759
What this trial is testing

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Shionogi 218
Large-scale testing (Phase 3)Not Yet RecruitingNCT07404553
What this trial is testing

SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

Who this might be right for
Hypercholesterolemia
Beijing Suncadia Pharmaceuticals Co., Ltd 126
Early research (Phase 1)Study completedNCT00541229
What this trial is testing

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT01296412
What this trial is testing

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 653
Large-scale testing (Phase 3)Study completedNCT02926937
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 399
Large-scale testing (Phase 3)Study completedNCT00683657
What this trial is testing

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 93
Large-scale testing (Phase 3)Study completedNCT02324569
What this trial is testing

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 240
Large-scale testing (Phase 3)Study completedNCT02096705
What this trial is testing

Phase III Insulin Add-On Asia Regional Program - ST

Who this might be right for
Diabetes
AstraZeneca 477
Large-scale testing (Phase 3)Active Not RecruitingNCT06672172
What this trial is testing

HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 284
Post-approval studies (Phase 4)Study completedNCT00870194
What this trial is testing

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 255
Testing effectiveness (Phase 2)Ended earlyNCT00814372
What this trial is testing

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 242
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT06109311
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 546
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation